• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

R-spondin 1在Apc小鼠中的表达通过改变Wnt和转化生长因子β信号传导来抑制肠道腺瘤的生长。

Expression of R-Spondin 1 in Apc Mice Suppresses Growth of Intestinal Adenomas by Altering Wnt and Transforming Growth Factor Beta Signaling.

作者信息

Lähde Marianne, Heino Sarika, Högström Jenny, Kaijalainen Seppo, Anisimov Andrey, Flanagan Dustin, Kallio Pauliina, Leppänen Veli-Matti, Ristimäki Ari, Ritvos Olli, Wu Katherine, Tammela Tuomas, Hodder Michael, Sansom Owen J, Alitalo Kari

机构信息

Translational Cancer Medicine Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Translational Cancer Medicine Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

出版信息

Gastroenterology. 2021 Jan;160(1):245-259. doi: 10.1053/j.gastro.2020.09.011. Epub 2020 Sep 14.

DOI:10.1053/j.gastro.2020.09.011
PMID:32941878
Abstract

BACKGROUND & AIMS: Mutations in the APC gene and other genes in the Wnt signaling pathway contribute to development of colorectal carcinomas. R-spondins (RSPOs) are secreted proteins that amplify Wnt signaling in intestinal stem cells. Alterations in RSPO genes have been identified in human colorectal tumors. We studied the effects of RSPO1 overexpression in Apc mutant mice.

METHODS

An adeno associated viral vector encoding RSPO1-Fc fusion protein, or control vector, was injected into Apcmice. Their intestinal crypts were isolated and cultured as organoids. which were incubated with or without RSPO1-Fc and an inhibitor of transforming growth factor beta receptor (TGFBR). Livers were collected from mice and analyzed by immunohistochemistry. Organoids and adenomas were analyzed by quantitative reverse-transcription PCR, single cell RNA sequencing, and immunohistochemistry.

RESULTS

Intestines from Apc mice injected with the vector encoding RSPO1-Fc had significantly deeper crypts, longer villi, with increased EdU labeling, indicating increased proliferation of epithelial cells, in comparison to mice given control vector. AAV-RSPO1-Fc-transduced Apc mice also developed fewer and smaller intestinal tumors and had significantly longer survival times. Adenomas of Apc mice injected with the RSPO1-Fc vector showed a rapid increase in apoptosis and in the expression of Wnt target genes, followed by reduced expression of messenger RNAs and proteins regulated by the Wnt pathway, reduced cell proliferation, and less crypt branching than adenomas of mice given the control vector. Addition of RSPO1 reduced the number of adenoma organoids derived from Apc mice and suppressed expression of Wnt target genes but increased phosphorylation of SMAD2 and transcription of genes regulated by SMAD. Inhibition of TGFBR signaling in organoids stimulated with RSPO1-Fc restored organoid formation and expression of genes regulated by Wnt. The TGFBR inhibitor restored apoptosis in adenomas from Apc mice expressing RSPO1-Fc back to the same level as in the adenomas from mice given the control vector.

CONCLUSIONS

Expression of RSPO1 in Apc mice increases apoptosis and reduces proliferation and Wnt signaling in adenoma cells, resulting in development of fewer and smaller intestinal tumors and longer mouse survival. Addition of RSPO1 to organoids derived from adenomas inhibits their growth and promotes proliferation of intestinal stem cells that retain the APC protein; these effects are reversed by TGFB inhibitor. Strategies to increase the expression of RSPO1 might be developed for the treatment of intestinal adenomas.

摘要

背景与目的

APC基因及Wnt信号通路中其他基因的突变促成结直肠癌的发生。R-spondins(RSPOs)是在肠道干细胞中增强Wnt信号传导的分泌蛋白。人类结直肠肿瘤中已发现RSPO基因的改变。我们研究了RSPO1过表达在Apc突变小鼠中的作用。

方法

将编码RSPO1-Fc融合蛋白的腺相关病毒载体或对照载体注射到Apc小鼠体内。分离它们的肠隐窝并培养成类器官,将其与有无RSPO1-Fc及转化生长因子β受体(TGFBR)抑制剂一起孵育。从小鼠体内收集肝脏并通过免疫组织化学进行分析。通过定量逆转录PCR、单细胞RNA测序和免疫组织化学对类器官和腺瘤进行分析。

结果

与注射对照载体的小鼠相比,注射编码RSPO1-Fc载体的Apc小鼠的肠道隐窝更深,绒毛更长,EdU标记增加,表明上皮细胞增殖增加。AAV-RSPO1-Fc转导的Apc小鼠还形成了更少、更小的肠道肿瘤,并且存活时间显著延长。注射RSPO1-Fc载体的Apc小鼠的腺瘤显示凋亡和Wnt靶基因表达迅速增加,随后Wnt通路调节的信使RNA和蛋白质表达减少,细胞增殖减少,隐窝分支比注射对照载体的小鼠的腺瘤少。添加RSPO1减少了源自Apc小鼠的腺瘤类器官数量,并抑制了Wnt靶基因的表达,但增加了SMAD2的磷酸化和SMAD调节的基因转录。在RSPO1-Fc刺激的类器官中抑制TGFBR信号传导可恢复类器官形成和Wnt调节的基因表达。TGFBR抑制剂将表达RSPO1-Fc的Apc小鼠腺瘤中的凋亡恢复到与注射对照载体的小鼠腺瘤相同的水平。

结论

Apc小鼠中RSPO1的表达增加腺瘤细胞中的凋亡,减少增殖和Wnt信号传导,导致形成更少、更小的肠道肿瘤和延长小鼠存活时间。向源自腺瘤的类器官中添加RSPO1会抑制其生长并促进保留APC蛋白的肠道干细胞增殖;这些作用可被TGFB抑制剂逆转。或许可以开发增加RSPO1表达的策略来治疗肠道腺瘤。

相似文献

1
Expression of R-Spondin 1 in Apc Mice Suppresses Growth of Intestinal Adenomas by Altering Wnt and Transforming Growth Factor Beta Signaling.R-spondin 1在Apc小鼠中的表达通过改变Wnt和转化生长因子β信号传导来抑制肠道腺瘤的生长。
Gastroenterology. 2021 Jan;160(1):245-259. doi: 10.1053/j.gastro.2020.09.011. Epub 2020 Sep 14.
2
MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.MET 信号转导介导肠道隐窝-绒毛发育、再生和腺瘤形成,并受干细胞 CD44 同种型的促进。
Gastroenterology. 2017 Oct;153(4):1040-1053.e4. doi: 10.1053/j.gastro.2017.07.008. Epub 2017 Jul 14.
3
TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.TRIB3 通过与β-catenin 和 TCF4 相互作用来增加结直肠癌细胞干细胞的干细胞特征和肿瘤发生。
Gastroenterology. 2019 Feb;156(3):708-721.e15. doi: 10.1053/j.gastro.2018.10.031. Epub 2018 Oct 24.
4
Comparative Analysis of Commercial and Home-Made Media on RSPO1/S6R Axis in Organoids with Different Wnt Backgrounds: A Methodological Guide for the Selection of Intestinal Patient-Derived Organoids Culture Media.不同 Wnt 背景下类器官中 RSPO1/S6R 轴上商业和自制培养基的比较分析:肠道患者来源类器官培养物选择的方法学指南。
Int J Mol Sci. 2024 Oct 26;25(21):11526. doi: 10.3390/ijms252111526.
5
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.在突变型 KRAS 的结直肠癌细胞中,SLC25A22 介导的谷氨酰胺分解作用降低 DNA 去甲基化以增加 WNT 信号、干性和耐药性。
Gastroenterology. 2020 Dec;159(6):2163-2180.e6. doi: 10.1053/j.gastro.2020.08.016. Epub 2020 Aug 16.
6
RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.RSPO3可扩大肠道干细胞和生态位区室并驱动肿瘤发生。
Gut. 2017 Jun;66(6):1095-1105. doi: 10.1136/gutjnl-2016-311606. Epub 2016 Aug 10.
7
Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma.人类结直肠衍生类器官的染色体工程构建传统锯齿状腺瘤模型
Gastroenterology. 2020 Feb;158(3):638-651.e8. doi: 10.1053/j.gastro.2019.10.009. Epub 2019 Oct 14.
8
Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.Foxf2 在肠成纤维细胞中通过抑制 Wnt 信号通路减少 Lgr5(+)干细胞数量并抑制腺瘤形成。
Gastroenterology. 2013 May;144(5):1001-11. doi: 10.1053/j.gastro.2013.01.045. Epub 2013 Jan 31.
9
Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-β.肠道腺瘤中的致癌突变调节由转化生长因子-β诱导的Bim介导的细胞凋亡。
Proc Natl Acad Sci U S A. 2014 May 27;111(21):E2229-36. doi: 10.1073/pnas.1406444111. Epub 2014 May 13.
10
Troy, a tumor necrosis factor receptor family member, interacts with lgr5 to inhibit wnt signaling in intestinal stem cells.Troy,一种肿瘤坏死因子受体家族成员,与 lgr5 相互作用,抑制肠道干细胞中的 wnt 信号通路。
Gastroenterology. 2013 Feb;144(2):381-391. doi: 10.1053/j.gastro.2012.10.048. Epub 2012 Nov 7.

引用本文的文献

1
Intermittent fasting inhibits the development of colorectal cancer in APC mice through gut microbiota and its related metabolites.间歇性禁食通过肠道微生物群及其相关代谢产物抑制Apc小鼠结直肠癌的发展。
Front Microbiol. 2025 May 29;16:1563224. doi: 10.3389/fmicb.2025.1563224. eCollection 2025.
2
Elevated Expression of STAT6, ERG, and miR-647 Expression as Predictive Biomarkers for Prostate Cancer.STAT6、ERG的高表达及miR-647表达作为前列腺癌的预测生物标志物
Int J Gen Med. 2025 Apr 10;18:2067-2075. doi: 10.2147/IJGM.S512606. eCollection 2025.
3
MCT4: a key player influencing gastric cancer metastasis and participating in the regulation of the metastatic immune microenvironment.
单羧酸转运蛋白4:影响胃癌转移并参与调节转移性免疫微环境的关键因子。
J Transl Med. 2025 Mar 5;23(1):276. doi: 10.1186/s12967-025-06279-8.
4
Shen-Bai-Jie-Du decoction suppresses the progression of colorectal adenoma to carcinoma through regulating gut microbiota and short-chain fatty acids.参白解毒汤通过调节肠道微生物群和短链脂肪酸抑制大肠腺瘤向癌的进展。
Chin Med. 2024 Oct 28;19(1):149. doi: 10.1186/s13020-024-01019-4.
5
Identification and Validation of Immune Implication of R-Spondin 1 and an R-Spondin 1-Related Prognostic Signature in Esophagus Cancer.食管癌中R-spondin 1的免疫意义及R-spondin 1相关预后特征的鉴定与验证
Int J Genomics. 2024 May 29;2024:7974277. doi: 10.1155/2024/7974277. eCollection 2024.
6
Enhanced Apc adenoma formation after epithelial CUL4B deletion by recruitment of myeloid-derived suppressor cells.上皮细胞 CUL4B 缺失通过招募髓源性抑制细胞促进 APC 腺瘤形成。
Neoplasia. 2024 Jul;53:101005. doi: 10.1016/j.neo.2024.101005. Epub 2024 May 17.
7
Sulfation of chondroitin and bile acids converges to antagonize Wnt/-catenin signaling and inhibit APC deficiency-induced gut tumorigenesis.硫酸软骨素和胆汁酸的硫酸化作用共同拮抗Wnt/β-连环蛋白信号传导,并抑制APC缺陷诱导的肠道肿瘤发生。
Acta Pharm Sin B. 2024 Mar;14(3):1241-1256. doi: 10.1016/j.apsb.2023.12.006. Epub 2023 Dec 16.
8
Loss of ZNRF3/RNF43 Unleashes EGFR in Cancer.ZNRF3/RNF43缺失在癌症中释放表皮生长因子受体(EGFR)
bioRxiv. 2024 Dec 16:2024.01.10.574969. doi: 10.1101/2024.01.10.574969.
9
Sulfoconjugation of protein peptides and glycoproteins in physiology and diseases.蛋白质肽和糖蛋白的磺酸化在生理和疾病中的作用。
Pharmacol Ther. 2023 Nov;251:108540. doi: 10.1016/j.pharmthera.2023.108540. Epub 2023 Sep 28.
10
Establishment of a large-scale patient-derived high-risk colorectal adenoma organoid biobank for high-throughput and high-content drug screening.建立一个大规模的基于患者的高危结直肠腺瘤类器官生物库,用于高通量和高内涵药物筛选。
BMC Med. 2023 Sep 4;21(1):336. doi: 10.1186/s12916-023-03034-y.